MCID: NGH001
MIFTS: 51

Night Blindness

Categories: Eye diseases, Rare diseases, Metabolic diseases

Aliases & Classifications for Night Blindness

MalaCards integrated aliases for Night Blindness:

Name: Night Blindness 12 72 51 41 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:8499
ICD10 32 H53.6 H53.60
ICD9CM 34 368.6 368.60
MeSH 41 D009755
UMLS 69 C0028077

Summaries for Night Blindness

MalaCards based summary : Night Blindness is related to x-linked congenital stationary night blindness and night blindness, congenital stationary, type 2a, and has symptoms including visual manifestations, visual disturbance and metamorphopsia. An important gene associated with Night Blindness is PDE6B (Phosphodiesterase 6B), and among its related pathways/superpathways are Metabolism of fat-soluble vitamins and Phototransduction. The drugs Epinephrine and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include eye, liver and testes, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 72 Nyctalopia /ˌnɪktəlˈoʊpiə/ (from Greek νύκτ-, nykt- \"night\"; ἀλαός, alaos \"blind, not seeing\", and... more...

Related Diseases for Night Blindness

Diseases in the Night Blindness family:

Acquired Night Blindness Hereditary Night Blindness

Diseases related to Night Blindness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 122)
# Related Disease Score Top Affiliating Genes
1 x-linked congenital stationary night blindness 34.6 CACNA1F NYX
2 night blindness, congenital stationary, type 2a 34.5 CACNA1F NYX
3 night blindness, congenital stationary, type 1e 34.1 CACNA1F GPR179 NYX
4 autosomal dominant congenital stationary night blindness 33.9 GNAT1 PDE6B RHO
5 night blindness, congenital stationary, type 1b 33.4 GPR179 GRM6 LRIT3 NYX TRPM1
6 autosomal recessive congenital stationary night blindness 33.1 GNAT1 GNB3 GRM6 SLC24A1
7 hereditary night blindness 32.4 CACNA1F GRK1 GRM6 NYX RDH5 RHO
8 melanoma-associated retinopathy 31.9 RHO SAG TRPM1
9 fundus albipunctatus 30.6 CACNA1F GNAT1 GRK1 PDE6B RDH5 RHO
10 retinitis pigmentosa 30.2 CACNA1F GNAT1 GRK1 NYX PDE6B RDH5
11 myopia 29.9 CACNA1F GNAT1 GRM6 NYX RHO
12 aland island eye disease 29.8 CACNA1F NYX
13 retinal degeneration 29.7 PDE6B RHO SAG
14 retinoschisis 1, x-linked, juvenile 29.6 CACNA1F NYX
15 congenital stationary night blindness 28.6 CABP4 CACNA1F GNAT1 GNB3 GPR179 GRK1
16 night blindness, congenital stationary, type 1a 12.6
17 night blindness, congenital stationary, autosomal dominant 2 12.5
18 night blindness, congenital stationary, type 1d 12.5
19 night blindness, congenital stationary, type 1f 12.5
20 night blindness, congenital stationary, autosomal dominant 3 12.4
21 night blindness, congenital stationary, autosomal dominant 1 12.4
22 night blindness, congenital stationary, type 1h 12.4
23 night blindness, congenital stationary, type 1c 12.4
24 night blindness, congenital stationary, type 1g 12.4
25 night blindness-skeletal anomalies-dysmorphism syndrome 12.3
26 acquired night blindness 12.2
27 oguchi disease 1 12.1
28 chondroectodermal dysplasia with night blindness 12.1
29 cone-rod synaptic disorder, congenital nonprogressive 11.9
30 oguchi disease 2 11.9
31 keratomalacia 11.8
32 retinal cone dystrophy 3a 11.7
33 retinal cone dystrophy 3b 11.7
34 choroideremia 11.4
35 refsum disease, classic 11.2
36 bietti crystalline corneoretinal dystrophy 11.0
37 gyrate atrophy of choroid and retina 11.0
38 enhanced s-cone syndrome 11.0
39 late-onset retinal degeneration 11.0
40 cone-rod dystrophy 16 11.0
41 cone-rod dystrophy 2 10.8
42 wagner vitreoretinopathy 10.8
43 retinitis pigmentosa 9 10.8
44 leber congenital amaurosis 2 10.8
45 jalili syndrome 10.8
46 senior-loken syndrome 1 10.8
47 retinitis pigmentosa 3 10.8
48 nystagmus 1, congenital, x-linked 10.8
49 retinitis pigmentosa 2 10.8
50 birdshot chorioretinopathy 10.8

Graphical network of the top 20 diseases related to Night Blindness:



Diseases related to Night Blindness

Symptoms & Phenotypes for Night Blindness

UMLS symptoms related to Night Blindness:


visual manifestations, visual disturbance, metamorphopsia, subjective visual disturbance, unspecified, amaurosis fugax, photophobia, other specified visual disturbances

GenomeRNAi Phenotypes related to Night Blindness according to GeneCards Suite gene sharing:

25 (show all 15)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-118 9.58 CABP4
2 Increased shRNA abundance (Z-score > 2) GR00366-A-124 9.58 RDH5
3 Increased shRNA abundance (Z-score > 2) GR00366-A-140 9.58 CABP4
4 Increased shRNA abundance (Z-score > 2) GR00366-A-151 9.58 CABP4
5 Increased shRNA abundance (Z-score > 2) GR00366-A-159 9.58 CABP4
6 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.58 TRPM1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.58 RDH5
8 Increased shRNA abundance (Z-score > 2) GR00366-A-189 9.58 RDH5 TRPM1 CABP4
9 Increased shRNA abundance (Z-score > 2) GR00366-A-194 9.58 CABP4
10 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.58 CABP4
11 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.58 TRPM1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.58 RDH5 TRPM1
13 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.58 TRPM1
14 Increased shRNA abundance (Z-score > 2) GR00366-A-80 9.58 TRPM1
15 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.58 CABP4

MGI Mouse Phenotypes related to Night Blindness:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.7 CABP4 CACNA1F GNAT1 GNB3 GRK1 GRM6
2 vision/eye MP:0005391 9.5 LRIT3 NYX PDE6B RDH5 RHO SAG

Drugs & Therapeutics for Night Blindness

Drugs for Night Blindness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 90)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
2
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
3
Albendazole Approved, Vet_approved Phase 4 54965-21-8 2082
4
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
5 Racepinephrine Approved Phase 4 329-65-7
6
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 68-26-8, 11103-57-4 445354
7 Retinol palmitate Phase 4,Phase 3,Phase 2,Early Phase 1
8 Micronutrients Phase 4,Phase 3,Phase 2,Early Phase 1
9 Trace Elements Phase 4,Phase 3,Phase 2,Early Phase 1
10 Vitamins Phase 4,Phase 3,Phase 2,Early Phase 1
11 Protective Agents Phase 4,Phase 3,Phase 2,Early Phase 1
12 Antioxidants Phase 4,Phase 3,Phase 2,Early Phase 1
13 Prednisolone acetate Phase 4
14 glucocorticoids Phase 4,Phase 2
15 Methylprednisolone acetate Phase 4
16 Methylprednisolone Hemisuccinate Phase 4
17 Gastrointestinal Agents Phase 4,Phase 2
18 Neuroprotective Agents Phase 4
19 Hormone Antagonists Phase 4,Phase 2
20 Hormones Phase 4,Phase 2
21 Anthelmintics Phase 4
22 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
23 Peripheral Nervous System Agents Phase 4,Phase 2
24 Epinephryl borate Phase 4
25 Antiemetics Phase 4,Phase 2
26 Anti-Infective Agents Phase 4
27 Prednisolone hemisuccinate Phase 4
28 Prednisolone phosphate Phase 4
29 Anti-Inflammatory Agents Phase 4,Phase 2
30 Antimitotic Agents Phase 4
31 Antineoplastic Agents, Hormonal Phase 4,Phase 2
32 Antiprotozoal Agents Phase 4
33 Antiparasitic Agents Phase 4
34 Autonomic Agents Phase 4,Phase 2
35 retinol Nutraceutical Phase 4,Phase 3,Phase 2,Early Phase 1
36
Iron Approved Phase 2, Phase 3, Early Phase 1 7439-89-6 23925
37
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
38
Lutein Approved, Investigational, Nutraceutical Phase 2, Phase 3 127-40-2 6433159
39 Tocopherol Approved, Investigational, Nutraceutical Phase 2, Phase 3
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
41
Vitamin E Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-02-9 14985
42
B-Carotene Approved, Nutraceutical Phase 3,Phase 2 7235-40-7 5280489
43 Orange Approved, Nutraceutical Phase 3
44 Vaccines Phase 2, Phase 3
45 Carotenoids Phase 3,Phase 2
46 Ferrous fumarate Phase 3
47 Tin Fluorides Phase 2, Phase 3
48 Tocopherols Phase 2, Phase 3
49 Tocotrienols Phase 2, Phase 3
50 Hematinics Phase 3

Interventional clinical trials:

(show top 50) (show all 66)

# Name Status NCT ID Phase Drugs
1 Adrenal Cortical Function and Vitamin A Deficiency in Sepsis Completed NCT03152474 Phase 4 Solumedrol 20mg;Vitamin A 100,000 IU
2 Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6 Completed NCT00222547 Phase 4 Vitamin A;Albendazole
3 Efficacy of β-carotene Biofortified Maize in Reducing Vitamin A Deficiency Among Children Completed NCT01695148 Phase 3
4 Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status Completed NCT02804490 Phase 3
5 Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit Completed NCT02043223 Phase 2, Phase 3
6 Impact of Maternal Supplementation With Dual Megadose of Vitamin A Completed NCT00742937 Phase 2, Phase 3
7 Trial of the Impact of Vitamin A on Maternal Mortality Completed NCT00211341 Phase 3
8 Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh Completed NCT00198822 Phase 3
9 Sub-clinical Inflammation and Iron Supplementation Completed NCT01198574 Phase 3
10 Carotenoid Supplementation and Normal Ocular Health Completed NCT02147171 Phase 2, Phase 3
11 Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh Terminated NCT00128557 Phase 3 vitamin A supplementation (50,000 IU)
12 Effect of Vitamin A Supplementation on Immune Responses in Human Neonates Unknown status NCT01476358 Phase 2
13 Vitamin A Absorption From Cassava in Women Completed NCT01381276 Phase 2
14 Vitamin A Equivalence of Plant Carotenoids in Children Completed NCT00680212 Phase 2
15 Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission Completed NCT00053612 Phase 2 Vitamin A
16 Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates Active, not recruiting NCT00198718 Phase 2 Vitamin A (retinyl palmitate)
17 Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study Enrolling by invitation NCT02804360 Phase 2
18 Gene Therapy for Gyrate Atrophy Completed NCT00001735 Phase 1
19 Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye Completed NCT00063765 Phase 1 Ciliary Neurotrophic Factor Implant NT-501
20 Vitamin A Supplementation in Preterm Infants Unknown status NCT00063596 Vitamin A supplementation
21 Nutributter Programming to Prevent Undernutrition: an Evaluation Unknown status NCT01552512
22 Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene Completed NCT00569023
23 Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection Completed NCT02363985
24 Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function Completed NCT01583972
25 Efficacy of Vitamin A in Fortified Extruded Rice in School Children Completed NCT01199445 Early Phase 1
26 Newborn Vitamin A (VA) Supplementation Pilot Project, Pakistan Completed NCT00674089
27 Dietary Vitamin A Requirement in Chinese Children and the New Technology of Dietary Assessment Completed NCT01559766
28 Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants Completed NCT02027610
29 An Efficacy Trial of Iron, Zinc and Vitamin A Fortified Rice in Children in Satun, Thailand Completed NCT01061307 Early Phase 1
30 Retinol Equivalence of Plant Carotenoids in Children Completed NCT00082420
31 Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality Completed NCT02965534
32 Vitamin A Liver Reserves and Serum Markers of Vitamin A in US Adults at Time of Death Completed NCT03305042
33 The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children Completed NCT02627222
34 Efficacy of Yellow Cassava to Improve Vitamin A Status of Kenyan School Children Completed NCT01614483
35 Visual Activity Evoked by Infrared in Humans After Dark Adaptation Completed NCT02909985
36 Using Stable Isotopes to Assess the Effectiveness of Vitamin A Supplementation in Cameroon Completed NCT03383744
37 Vitamin A Equivalence of the Provitamin A in Biofortified Bananas Completed NCT02702622
38 Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari Completed NCT02210507
39 Effect of Daily Consumption of Orange Maize on Breast Milk Retinol in Lactating Zambian Women Completed NCT01922713
40 Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status Completed NCT01420406
41 Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age Completed NCT00453648
42 Effect of SNPs in the BCMO1 Enzyme Completed NCT02276014
43 Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method Completed NCT02996513
44 A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial Completed NCT00374023 Zinc, or Vitamin A or both
45 Making Maternal Post-partum Vitamin A Supplementation Effective: The Role of Timing and Inflammation Completed NCT00952640
46 Vitamin A and Maternal-infant Flu Vaccine Response Completed NCT00817661
47 Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g Completed NCT02102711
48 High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM Completed NCT00388921 Vitamin A
49 Newly Formulated, Extruded Fortified-blended Foods for Food Aid: the MFFAPP Tanzania Efficacy Study Completed NCT02847962
50 A Randomized Controlled Trial Testing The Effect Of A Multi-Nutrient Fortified Juice Completed NCT01909063

Search NIH Clinical Center for Night Blindness

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: night blindness

Genetic Tests for Night Blindness

Anatomical Context for Night Blindness

MalaCards organs/tissues related to Night Blindness:

38
Eye, Liver, Testes, Breast, Bone, Retina, Pancreas

Publications for Night Blindness

Articles related to Night Blindness:

(show top 50) (show all 399)
# Title Authors Year
1
Cone dystrophy and ectopic synaptogenesis in a Cacna1f loss of function model of congenital stationary night blindness (CSNB2A). ( 29179637 )
2018
2
Long-Term Clinical Course in a Patient with Complete Congenital Stationary Night Blindness. ( 28512427 )
2017
3
Structural role of the T94I rhodopsin mutation in congenital stationary night blindness. ( 27458239 )
2016
4
Biallelic Mutations in GNB3 Cause a Unique Form of Autosomal-Recessive Congenital Stationary Night Blindness. ( 27063057 )
2016
5
Next-generation sequencing confirms the implication of SLC24A1 in autosomal-recessive congenital stationary night blindness. ( 26822852 )
2016
6
Amyloid Precursor-Like Protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, functional and molecular characteristics. ( 27267879 )
2016
7
Novel TRPM1 mutations in two Chinese families with early-onset high myopia, with or without complete congenital stationary night blindness. ( 27803854 )
2016
8
Mutation screening of the LRIT3, CABP4, and GPR179 genes in Chinese patients with Schubert-Bornschein congenital stationary night blindness. ( 27428514 )
2016
9
Clinical Characteristics, Mutation Spectrum, and Prevalence of A8land Eye Disease/Incomplete Congenital Stationary Night Blindness in Denmark. ( 28002560 )
2016
10
Psychophysical measures of visual function and everyday perceptual experience in a case of congenital stationary night blindness. ( 27601873 )
2016
11
Characterization of Ribozymes Targeting a Congenital Night Blindness Mutation in Rhodopsin Mutation. ( 26427453 )
2016
12
Congenital stationary night blindness with hypoplastic discs, negative electroretinogram and thinning of the inner nuclear layer. ( 27084085 )
2016
13
Redundant contribution of a Transient Receptor Potential cation channel Member 1 exon 11 single nucleotide polymorphism to equine congenital stationary night blindness. ( 27329127 )
2016
14
Recurrent episodes of night blindness in a patient with short bowel syndrome. ( 26507840 )
2015
15
Acquired night blindness due to bad eating patterns. ( 25804276 )
2015
16
Mutations in GRM6 identified in consanguineous Pakistani families with congenital stationary night blindness. ( 26628857 )
2015
17
Determinants of gestational night blindness in pregnant women from Rio de Janeiro, Brazil. ( 26055085 )
2015
18
Night blindness due to vitamin A deficiency associated with resected adenocarcinoma of the pancreas. ( 25709934 )
2015
19
A new mouse model for stationary night blindness with mutant Slc24a1 explains the pathophysiology of the associated human disease. ( 26246500 )
2015
20
Twenty-five thousand years of fluctuating selection on leopard complex spotting and congenital night blindness in horses. ( 25487337 )
2015
21
Identification of a new mutant allele, Grm6(nob7), for complete congenital stationary night blindness. ( 26241901 )
2015
22
Two Novel NYX Gene Mutations in the Chinese Families with X-linked Congenital Stationary Night Blindness. ( 26234941 )
2015
23
Assessment of selenium and mercury in biological samples of normal and night blindness children of age groups (3-7) and (8-12) years. ( 25655123 )
2015
24
Isotretinoin-Induced Night Blindness. ( 26288455 )
2015
25
Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. ( 26310623 )
2015
26
A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness. ( 26368928 )
2015
27
Cacna1f gene decreased contractility of skeletal muscle in rat model with congenital stationary night blindness. ( 25748727 )
2015
28
Night blindness and ancient remedy. ( 25774260 )
2014
29
Seasonal variation in night blindness incidence among Union soldiers in the US Civil War. ( 25200714 )
2014
30
Night blindness due to vitamin A deficiency associated with copper deficiency myelopathy secondary to bowel bypass surgery. ( 24781845 )
2014
31
Molecular profiling of complete congenital stationary night blindness: a pilot study on an Indian cohort. ( 24715752 )
2014
32
Congenital stationary night blindness: An analysis and update of genotype-phenotype correlations and pathogenic mechanisms. ( 25307992 )
2014
33
Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2. ( 24466230 )
2014
34
Night blindness and Crohn's disease. ( 24715231 )
2014
35
A truncated form of rod photoreceptor PDE6 I^-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the I^-subunit. ( 24760071 )
2014
36
Prevalence of night blindness in Bashagard district in Hormozgan, Iran, in 2011. ( 25763164 )
2014
37
Lrit3 deficient mouse (nob6): a novel model of complete congenital stationary night blindness (cCSNB). ( 24598786 )
2014
38
Isotretinoin and night blindness. ( 25117163 )
2014
39
Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2. ( 24796500 )
2014
40
The role of prenatal nutrition assistance on the prevalence of night blindness in pregnant adults. ( 24951995 )
2014
41
Sorting out Co-occurrence of Rare Monogenic Retinopathies: Stargardt Disease Co-existing with Congenital Stationary Night Blindness. ( 24397708 )
2014
42
Color vision abnormality as an initial presentation of the complete type of congenital stationary night blindness. ( 23966763 )
2013
43
Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. ( 23872075 )
2013
44
Evidence for a retroviral insertion in TRPM1 as the cause of congenital stationary night blindness and leopard complex spotting in the horse. ( 24167615 )
2013
45
Arrayed primer extension microarray for the analysis of genes associated with congenital stationary night blindness. ( 23296619 )
2013
46
Photoreceptor and postreceptor responses in congenital stationary night blindness. ( 23761088 )
2013
47
Assessment of night vision problems in patients with congenital stationary night blindness. ( 23658786 )
2013
48
Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. ( 23714322 )
2013
49
A historical perspective on the early treatment of night blindness and the use of dubious and unproven treatment strategies for patients with retinitis pigmentosa. ( 23911150 )
2013
50
Electroretinographic findings in a patient with congenital stationary night blindness due to a novel NYX mutation. ( 23289809 )
2013

Variations for Night Blindness

Copy number variations for Night Blindness from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 175785 3 44200000 50600000 Gain or loss GNAT1 Night blindness

Expression for Night Blindness

Search GEO for disease gene expression data for Night Blindness.

Pathways for Night Blindness

GO Terms for Night Blindness

Cellular components related to Night Blindness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 photoreceptor inner segment GO:0001917 9.43 GNAT1 RHO SAG
2 photoreceptor outer segment membrane GO:0042622 9.32 GNAT1 RHO
3 photoreceptor outer segment GO:0001750 9.26 CACNA1F GNAT1 RHO SAG
4 new growing cell tip GO:0035841 9.16 GRM6 TRPM1
5 photoreceptor disc membrane GO:0097381 8.92 GNAT1 GRK1 PDE6B RHO

Biological processes related to Night Blindness according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 visual perception GO:0007601 9.8 CABP4 CACNA1F GNAT1 GPR179 GRK1 GRM6
2 calcium ion transmembrane transport GO:0070588 9.72 CACNA1F SLC24A1 TRPM1
3 retina development in camera-type eye GO:0060041 9.67 GNAT1 GRM6 PDE6B RHO
4 regulation of rhodopsin mediated signaling pathway GO:0022400 9.65 GNAT1 GRK1 PDE6B RHO SAG
5 phototransduction GO:0007602 9.63 CABP4 GNAT1 RHO
6 detection of light stimulus involved in visual perception GO:0050908 9.58 CACNA1F GNAT1 GRM6
7 response to light stimulus GO:0009416 9.56 GNAT1 RHO
8 rhodopsin mediated signaling pathway GO:0016056 9.55 GNAT1 GRK1 PDE6B RHO SAG
9 sensory perception of light stimulus GO:0050953 9.54 GRM6 RHO
10 G-protein coupled glutamate receptor signaling pathway GO:0007216 9.52 GRM6 TRPM1
11 response to light intensity GO:0009642 9.51 GNAT1 SLC24A1
12 phototransduction, visible light GO:0007603 9.5 GNAT1 PDE6B RHO
13 cellular response to light stimulus GO:0071482 9.49 RHO TRPM1
14 detection of light stimulus GO:0009583 9.48 PDE6B RHO
15 response to stimulus GO:0050896 9.4 CACNA1F GNAT1 GRK1 GRM6 LRIT3 NYX
16 signal transduction GO:0007165 10.09 CABP4 GNAT1 GNB3 GRK1 GRM6 PDE6B

Molecular functions related to Night Blindness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signal transducer activity GO:0004871 9.26 GNAT1 GNB3 GRM6 RHO
2 calcium channel activity GO:0005262 8.8 CACNA1F SLC24A1 TRPM1

Sources for Night Blindness

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....